News
31.01.2019
Valneva Reports Positive Initial Booster Data and Final Phase 1 Data for its Lyme Disease Vaccine Candidate
29.01.2019
THE WINE DETECTIVES: HIGH-PRECISION CHEMICAL FINGERPRINT ALLOWS UNAMBIGUOUS IDENTIFICATION
23.01.2019
MARINOMED RESUMES OFFER PERIOD OF INITIAL PUBLIC OFFERING ON THE VIENNA STOCK EXCHANGE
16.01.2019
Valneva Confirms FY 2018 Guidance and Provides Initial Product Sales Revenue Guidance for 2019
10.01.2019
AOP Orphan Pharmaceuticals AG and Chord Therapeutics Announce a Partnership to Develop CRD1 (Cladribine) for Treatment of Orphan Autoimmune Diseases
07.01.2019
HOOKIPA Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead